Cargando…
Synthetic lethality of Mycobacterium tuberculosis NADH dehydrogenases is due to impaired NADH oxidation
Type 2 NADH dehydrogenase (Ndh-2) is an oxidative phosphorylation enzyme discussed as a promising drug target in different pathogens, including Plasmodium falciparum and Mycobacterium tuberculosis (Mtb). To kill Mtb, Ndh-2 needs to be inactivated together with the alternative enzyme type 1 NADH dehy...
Autores principales: | Xu, Yuanyuan, Ehrt, Sabine, Schnappinger, Dirk, Beites, Tiago |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120654/ https://www.ncbi.nlm.nih.gov/pubmed/37090679 http://dx.doi.org/10.1101/2023.04.10.536268 |
Ejemplares similares
-
Multiple acyl-CoA dehydrogenase deficiency kills Mycobacterium tuberculosis in vitro and during infection
por: Beites, Tiago, et al.
Publicado: (2021) -
Revealing the Membrane-Bound Catalytic Oxidation of
NADH by the Drug Target Type-II NADH Dehydrogenase
por: Godoy-Hernandez, Albert, et al.
Publicado: (2019) -
NADH Dehydrogenases in Pseudomonas aeruginosa Growth and Virulence
por: Torres, Angela, et al.
Publicado: (2019) -
Differences in mitochondrial NADH dehydrogenase activities in trypanosomatids
por: Čermáková, Petra, et al.
Publicado: (2021) -
Scale up of Transmembrane NADH Oxidation in Synthetic
Giant Vesicles
por: Wang, MinHui, et al.
Publicado: (2021)